Cargando…
Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis
Sepsis is a life-threatening condition with dysregulated host response to infection. It is a major determinant of mortality in the intensive care unit (ICU). Procalcitonin (PCT) is widely investigated for prognosis in patients with sepsis. Most of the studies have cited that elevated PCT concentrati...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022053/ https://www.ncbi.nlm.nih.gov/pubmed/33840923 http://dx.doi.org/10.4103/joacp.JOACP_388_19 |
_version_ | 1783674865058840576 |
---|---|
author | Patnaik, Rupali Azim, Afzal Mishra, Prabhaker |
author_facet | Patnaik, Rupali Azim, Afzal Mishra, Prabhaker |
author_sort | Patnaik, Rupali |
collection | PubMed |
description | Sepsis is a life-threatening condition with dysregulated host response to infection. It is a major determinant of mortality in the intensive care unit (ICU). Procalcitonin (PCT) is widely investigated for prognosis in patients with sepsis. Most of the studies have cited that elevated PCT concentrations and PCT non-clearance are associated with poor outcomes in patients with sepsis and some studies have cited as having no additional benefit. Most of the studies have evaluated single PCT measurement and correlated with prognosis and outcome in septic patients. Limited literature is there about serial PCT levels and its impact on the outcome of patients with sepsis. We searched literature through PubMed, Embase, Web of Knowledge, and the Cochrane Library from 2007 to 2017 and present a systematic review and meta-analysis of studies evaluating the utility of serial measurement of PCT for prognosis in critically ill patients. Articles that assessed PCT non-clearance as a marker of mortality data were included. The primary objective of this meta-analysis was to pool the results of all the available studies on serial PCT non-clearance as a mortality predictor and formulate overall area under receiver operating curve (AUROC). To find out the overall proportion of mortality in PCT non-clearance was our secondary objective. To detect the mortality using PCT non-clearance, ROC curve analysis was done. Area under curve (AUC) of the studies was varying between 0.52 and 0.86. Overall AUC was observed 0.711 (95% confidence interval (CI): 0.662–0.760) under fixed effect model and 0.708 (95% CI: 0.648–0.769) under random effect model. There was moderate variation among the studies, i.e., I(2) 50.80% (95% CI: 0.00–80.42%). The overall proportion of mortality was 37.54% with much heterogeneity (I(2) 88.24%) among the studies. PCT non-clearance is a fair predictor of mortality. Further studies are needed to define optimal cut off point for PCT non-clearance in ICU patients with sepsis. |
format | Online Article Text |
id | pubmed-8022053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-80220532021-04-08 Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis Patnaik, Rupali Azim, Afzal Mishra, Prabhaker J Anaesthesiol Clin Pharmacol Review Article Sepsis is a life-threatening condition with dysregulated host response to infection. It is a major determinant of mortality in the intensive care unit (ICU). Procalcitonin (PCT) is widely investigated for prognosis in patients with sepsis. Most of the studies have cited that elevated PCT concentrations and PCT non-clearance are associated with poor outcomes in patients with sepsis and some studies have cited as having no additional benefit. Most of the studies have evaluated single PCT measurement and correlated with prognosis and outcome in septic patients. Limited literature is there about serial PCT levels and its impact on the outcome of patients with sepsis. We searched literature through PubMed, Embase, Web of Knowledge, and the Cochrane Library from 2007 to 2017 and present a systematic review and meta-analysis of studies evaluating the utility of serial measurement of PCT for prognosis in critically ill patients. Articles that assessed PCT non-clearance as a marker of mortality data were included. The primary objective of this meta-analysis was to pool the results of all the available studies on serial PCT non-clearance as a mortality predictor and formulate overall area under receiver operating curve (AUROC). To find out the overall proportion of mortality in PCT non-clearance was our secondary objective. To detect the mortality using PCT non-clearance, ROC curve analysis was done. Area under curve (AUC) of the studies was varying between 0.52 and 0.86. Overall AUC was observed 0.711 (95% confidence interval (CI): 0.662–0.760) under fixed effect model and 0.708 (95% CI: 0.648–0.769) under random effect model. There was moderate variation among the studies, i.e., I(2) 50.80% (95% CI: 0.00–80.42%). The overall proportion of mortality was 37.54% with much heterogeneity (I(2) 88.24%) among the studies. PCT non-clearance is a fair predictor of mortality. Further studies are needed to define optimal cut off point for PCT non-clearance in ICU patients with sepsis. Wolters Kluwer - Medknow 2020 2021-01-18 /pmc/articles/PMC8022053/ /pubmed/33840923 http://dx.doi.org/10.4103/joacp.JOACP_388_19 Text en Copyright: © 2021 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Patnaik, Rupali Azim, Afzal Mishra, Prabhaker Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis |
title | Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis |
title_full | Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis |
title_fullStr | Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis |
title_full_unstemmed | Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis |
title_short | Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis |
title_sort | should serial monitoring of procalcitonin be done routinely in critically ill patients of icu: a systematic review and meta-analysis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022053/ https://www.ncbi.nlm.nih.gov/pubmed/33840923 http://dx.doi.org/10.4103/joacp.JOACP_388_19 |
work_keys_str_mv | AT patnaikrupali shouldserialmonitoringofprocalcitoninbedoneroutinelyincriticallyillpatientsoficuasystematicreviewandmetaanalysis AT azimafzal shouldserialmonitoringofprocalcitoninbedoneroutinelyincriticallyillpatientsoficuasystematicreviewandmetaanalysis AT mishraprabhaker shouldserialmonitoringofprocalcitoninbedoneroutinelyincriticallyillpatientsoficuasystematicreviewandmetaanalysis |